top of page
Executive Spotlights

Noema Pharma Appoints Dr. Ilise Lombardo as CEO to Drive Advancements in Clinical-Stage CNS Pipeline

Basel, Switzerland, June 21, 2023 (Globe Newswire) -- Noema Pharma, a clinical-stage biotech company targeting central nervous system disorders, welcomes Dr. Ilise Lombardo as their new Chief Executive Officer. With her extensive experience in the CNS space and a robust clinical pipeline, Dr. Lombardo is well-positioned to lead Noema in developing innovative therapies for debilitating CNS conditions and achieving key clinical milestones.

Read full article here.

Recent Posts

See All
Life Science Headlines
bottom of page